cefclidin and Prostatitis

cefclidin has been researched along with Prostatitis* in 1 studies

Other Studies

1 other study(ies) available for cefclidin and Prostatitis

Article	Year
[Clinical study of cefclidin on bacterial prostatitis]. Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:4 Cefclidin (CFCL), a new injectable cephem antibiotic, was used in the treatment of bacterial prostatitis. Concentration in prostatic fluid (PF): One hour after the i.v. administration of 1 g of CFCL the concentration of PF was 0.84 +/- 0.72 micrograms/ml (n = 4), the ratio of PF/serum being 2.24%. CFCL was administered at a dose of 1-2 g a day for 6.5 days on average. In acute bacterial prostatitis, the efficacy was evaluated as excellent or moderate in all 7 cases (100%), but in chronic cases, the effectiveness rate was as low as one out of 4 cases (25%). In safety profile, transient skin eruption was seen in one patient, but did not require further treatment. Besides this case, no side reactions or abnormal clinical values were encountered. In conclusion, CFCL was evaluated to be very useful in the treatment of acute bacterial prostatitis, caused by gram negative rods. Topics: Adult; Aged; Cephalosporins; Drug Evaluation; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prostatitis	1992

Article

Year

[Clinical study of cefclidin on bacterial prostatitis].

Hinyokika kiyo. Acta urologica Japonica, 1992, Volume: 38, Issue:4

Cefclidin (CFCL), a new injectable cephem antibiotic, was used in the treatment of bacterial prostatitis. Concentration in prostatic fluid (PF): One hour after the i.v. administration of 1 g of CFCL the concentration of PF was 0.84 +/- 0.72 micrograms/ml (n = 4), the ratio of PF/serum being 2.24%. CFCL was administered at a dose of 1-2 g a day for 6.5 days on average. In acute bacterial prostatitis, the efficacy was evaluated as excellent or moderate in all 7 cases (100%), but in chronic cases, the effectiveness rate was as low as one out of 4 cases (25%). In safety profile, transient skin eruption was seen in one patient, but did not require further treatment. Besides this case, no side reactions or abnormal clinical values were encountered. In conclusion, CFCL was evaluated to be very useful in the treatment of acute bacterial prostatitis, caused by gram negative rods.

Topics: Adult; Aged; Cephalosporins; Drug Evaluation; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prostatitis

1992